Ebola outbreak in DRC: Suspected cases rise to 1,028 as WHO urges coordinated response
Ebola outbreak in DRC escalates to 1,028 suspected cases; WHO calls for stronger coordination in Ituri province while DRC tests promising treatments and addresses cross-border risk.
The Ebola outbreak in DRC has intensified, with suspected cases reported at 1,028, prompting renewed calls for coordinated action and international support. The figure, confirmed by the Democratic Republic of Congo’s health authorities, reflects a sharp increase from 906 suspected cases reported the day before. WHO Director-General Tedros Adhanom Ghebreyesus visited the affected area and stressed the need for health and humanitarian actors to work under unified government leadership. Local engagement and listening to communities are being highlighted as central to slowing transmission.
Rising case tally and official figures
The DRC Ministry of Health reported the jump to 1,028 suspected infections on Saturday, citing data collected up to Friday. Minister Samuel Roger Kamba confirmed the rise and said authorities were intensifying surveillance and case investigation across affected zones. Officials emphasize that these are suspected cases pending laboratory confirmation and that numbers can change as investigations proceed. The rapid increase has alarmed public health teams and prompted calls for additional on-the-ground resources.
WHO visit underscores coordination gaps in Ituri
During his visit to Ituri province, WHO Director-General Tedros Adhanom Ghebreyesus urged better coordination between humanitarian and health agencies operating in the hotspot. He said efforts must be aligned with government leadership, and warned that fragmented responses undermine containment. Tedros repeatedly emphasized that communities themselves must be listened to and supported, arguing that local populations are best placed to identify needs and workable solutions. The WHO delegation characterized community engagement as a top priority in the immediate response.
Bundibugyo strain complicates containment
Health authorities have identified the outbreak strain as Bundibugyo, a rare variant of Ebola for which there is currently no widely deployed vaccine. WHO briefings in early May suggested the outbreak likely began approximately two months earlier, complicating efforts to trace chains of transmission. The rarity of the strain narrows available medical countermeasures and requires tailored clinical and public health strategies. Experts note that treatment protocols and protective measures remain essential while specialized therapeutics are evaluated.
Cross-border cases reported in Uganda
Authorities have also reported cases linked to the outbreak appearing across the border in Uganda, raising concerns about regional spread. Cross-border movement of people in affected border areas has heightened the urgency for coordinated screening and information sharing between neighbouring health services. Regional health partners are being urged to bolster surveillance at entry points and to harmonize clinical guidance. Officials stress that preventing further international spread depends on rapid detection and community cooperation in border districts.
Humanitarian groups warn of insufficient support
International medical organisations operating in the region have cautioned that available support and staffing levels may not be adequate for a mounting emergency. Médecins Sans Frontières and other NGOs have flagged shortages of trained personnel and logistical constraints that could delay case management and vaccination campaigns if needed. These concerns were echoed by field teams who report challenges reaching remote communities amid insecurity and poor transport links. The warnings underline the need for a scaled-up, well-coordinated international response.
DRC response: supplies, logistics and clinical trials
The DRC Ministry of Health has sought to allay some concerns by reporting that medical supplies are available and that logistical obstacles to distribution are being addressed. Officials say they are working to remove bottlenecks in transporting supplies and to expand testing capacity in affected provinces. Health authorities additionally reported that several promising treatments for the Bundibugyo strain are undergoing evaluation, with WHO assessing candidate vaccines and therapeutics for potential use. These efforts aim to reduce mortality and break transmission chains while clinical assessments proceed.
Calls for international backing to end the outbreak
Despite the DRC’s well-established experience responding to epidemics, WHO leadership and national officials are appealing for more international support to accelerate containment. Tedros called for increased funding, technical assistance and rapid deployment of surge teams to back local responders. Donor governments and multilateral partners are being asked to prioritise logistics, laboratory capacity and community engagement programming. Observers say that sustained international commitment will be critical to preventing a broader regional health emergency.
The situation remains fluid and health authorities stress the importance of timely reporting, targeted humanitarian access and respectful community dialogue to control the Ebola outbreak in DRC.